Prollenium Medical Technologies
Prollenium Medical Technologies, founded 2002 in Richmond Hill, Canada, manufactures HA-based dermal fillers (Revanesse), skin rejuvenation technology (VAMP), and aesthetic cannulas (SoftFil) at an ISO 13485-certified, FDA-approved facility, selling globally to aesthetic practitioners and distributors via direct sales and training through the PACE program.
- Company typePrivate
- Founded2002
- HeadquartersRichmond Hill, Canada
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Prollenium Medical Technologies does
Prollenium Medical Technologies, founded in 2002 and headquartered in Richmond Hill, Ontario, manufactures and globally distributes hyaluronic acid (HA)-based dermal fillers and related aesthetic devices. Its product portfolio centers on three brands: Revanesse, a range of HA injectable dermal fillers; VAMP, an advanced skin rejuvenation technology launched in 2024; and SoftFil, a cannula brand acquired to extend the company's offerings into the injection delivery device category. Prollenium positions itself as the only manufacturer in North America providing end-to-end product development and manufacturing within a single ISO 13485:2016-certified, FDA-approved facility, supporting quality control and supply chain efficiency.
The company operates a hybrid go-to-market combining direct field sales to aesthetic practitioners with an authorized global distributor network, supplemented by three product-specific microsites (Revanesse.com, VAMP Aesthetics, SoftFil.com). Its primary customer segments are aesthetic practitioners, including dermatologists and plastic surgeons performing injectable treatments, and the distributors that supply them; end consumers are a secondary segment reached via practitioner channels. Pricing is not publicly disclosed and follows contact-based B2B transactions through direct sales and distributor channels.
Complementing the product business, Prollenium runs the PACE (Prollenium Advanced Clinical Education) program, a training ecosystem partnering with over 150 medical professionals to deliver in-clinic training, cadaver labs, full-day symposiums, and webinars. In April 2026, PACE was extended into a scalable digital format via the PACE Training & Education Portal developed with Harley Academy, incorporating AI-powered anatomy tools, personalized learning pathways, and the proprietary GEM evidence-based methodology, used as a relationship-building and product-adoption lever across the practitioner base.
Prollenium Medical Technologies firmographics
Firmographics- Name
- Prollenium Medical Technologies
- Legal name
- Prollenium Medical Technologies
- Website
- https://prollenium.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Prollenium Medical Technologies, founded 2002 in Richmond Hill, Canada, manufactures HA-based dermal fillers (Revanesse), skin rejuvenation technology (VAMP), and aesthetic cannulas (SoftFil) at an ISO 13485-certified, FDA-approved facility, selling globally to aesthetic practitioners and distributors via direct sales and training through the PACE program.
- Ownership category
- akta.pro rank
Prollenium Medical Technologies industry classification
Industry- Product category
- Medical Aesthetic Devices
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
- akta.pro secondary industries
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI)
Keywords
Where Prollenium Medical Technologies is headquartered
LocationHeadquarters
- HQ city
- Richmond Hill
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Prollenium Medical Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Aesthetic Product Sales: Prollenium generates revenue through the sale of medical aesthetic products including HA injectable dermal fillers (Revanesse), skin rejuvenation technology (VAMP), and aesthetic cannulas (SoftFil) to aesthetic practitioners and clinics. Revenue is derived from product sales to healthcare providers.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Prollenium Medical Technologies product offering
Product offeringCore offering
Prollenium Medical Technologies manufactures and sells hyaluronic acid (HA) based dermal fillers under the Revanesse brand, advanced skin rejuvenation technology under VAMP, and aesthetic cannulas under the SoftFil brand for use by aesthetic practitioners. The company complements its product portfolio with the PACE clinical education program, offering in-clinic training, cadaver labs, symposiums, webinars, and a digital education portal to train practitioners and drive product adoption.
Product overview
Prollenium Medical Technologies offers a portfolio of medical aesthetic products and services. The core product lineup includes Revanesse® (a full range of HA injectable dermal fillers), VAMP™ (advanced skin rejuvenation technology), and SoftFil® (aesthetic cannulas). These products are manufactured at the company's North American facility that provides end-to-end product development and manufacturing in one location. Complementing the product portfolio, the company operates PACE (Prollenium Advanced Clinical Education), an evidence-based training ecosystem that includes in-person training, cadaver labs, symposiums, webinars, and a digital education portal to support aesthetic practitioners in developing clinical and practice skills.
Differentiator
Problem solved
Functional benefit
Brands
- PACE: Prollenium Advanced Clinical Education - an evidence-based training ecosystem for medical aesthetics practitioners
- Revanesse®
- VAMP™
- SoftFil®
Products and services
- Revanesse® HA Injectables
Companies that use Prollenium Medical Technologies
Customer profileSegments3 records
Ideal customer profiles2 records
Prollenium Medical Technologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
Prollenium Medical Technologies partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Harley AcademycoreProllenium collaborated with Harley Academy to develop the PACE Training & Education Portal, a digital learning platform providing on-demand access to educational resources, AI-powered anatomy tools, clinical insights, and business development modules. The partnership extends Prollenium's in-person training programs into a scalable digital format.
- SoftFilcoreProllenium acquired SoftFil, a leading brand of aesthetic cannulas designed to enhance safety, simplicity, and comfort for injectors. This acquisition expands Prollenium's product portfolio and manufacturing capabilities in the aesthetic devices space.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Prollenium Medical Technologies competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Prollenium Medical Technologies social profiles
Digital presenceProllenium Medical Technologies compliance and trust
Trust signalCompliance2 records
Prollenium Medical Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Prollenium Medical Technologies leadership team
Management profileNumber of profiles
Profiles4 records
Prollenium Medical Technologies subsidiaries and ownership
Company hierarchySubsidiaries1 record
Prollenium Medical Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Prollenium Medical Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Prollenium Medical Technologies
What does Prollenium Medical Technologies do?
Prollenium Medical Technologies manufactures and sells hyaluronic acid (HA) based dermal fillers under the Revanesse brand, advanced skin rejuvenation technology under VAMP, and aesthetic cannulas under the SoftFil brand for use by aesthetic practitioners. The company complements its product portfolio with the PACE clinical education program, offering in-clinic training, cadaver labs, symposiums, webinars, and a digital education portal to train practitioners and drive product adoption.
Is Prollenium Medical Technologies a public or private company?
Prollenium Medical Technologies is a private company. It is classified as unknown and is currently operating.
When was Prollenium Medical Technologies founded?
Prollenium Medical Technologies was founded in 2002. It employs 101 to 250 people.
Where is Prollenium Medical Technologies based?
Prollenium Medical Technologies is headquartered in Richmond Hill, Canada, in the North America region.
How does Prollenium Medical Technologies make money?
One revenue line is on record: medical Aesthetic Product Sales.
Does Prollenium Medical Technologies have an API?
No public API is recorded for Prollenium Medical Technologies.
What industry is Prollenium Medical Technologies in?
Prollenium Medical Technologies's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 325412 and its SIC code is 2833.